Tipranavir

Medical Advocates
Tipranavir (Aptivus)

Main Page

New and Noteworthy
FDA/EU Updates
Journal Data
Conference Data
Protease Inhibitors: General Data
Pediatric Data
Perinatal Data

ARV Main Page

Main New/Newsworthy

Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: March 12, 2010
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

March 2010

Factors predictive of successful darunavir/ritonavir-based therapy in highly antiretroviral-
experienced HIV-1-infected patients (the DARWEST study).
Delaugerre C, Buyck JF, Peytavin G, et al J Clin Virol. 2010 Mar;47(3):248-52.

February 2010

POSTER
Ultradeep Sequencing Refines Phenotypic Predictions to Darunavir, Etravirine, and
Other Protease and Reverse Transcriptase Inhibitors in Heavily Pre-treated Subjects
Infected with Multidrug Resistant HIV-1
F Codoñer, C Pou, A Thielen, et al 17th CROI
PDF Poster     Abstract

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug
Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir.
Dumond JB, Vourvahis M, Rezk NL, et al Clin Pharmacol Ther. 2010 Feb 10

FDA/EU Updates

NEWS RELEASE
New Aptivus (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and
Adolescent HIV Patients Aptivus Oral Solution Also Approved for Treatment-Experienced
Adult Patients
Boehringer Ingelheim June 24, 2008

NEWS RELEASE
European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus)
Boehringer Ingelheim April 28, 2008

NEWS RELEASE
FDA granted traditional approval to Aptivus (tipranavir) on October 4, 2007,
US FDA October 05, 2007

NEWS RELEASE
Aptivus (tipranavir) Capsules Granted Full Approval by the US FDA
Boehringer Ingelheim October 05, 2007

FULL-TEXT DOCUMENT
Tipranavir/Ritonavir Intracranial Hemorrhage Warning
US FDA June 20, 2006

NEWS RELEASE
FDA Grants Accelerated Approval of Tipranavir
US FDA June 23, 2005

Perinatal Data

Guidelines

    United States

          Internet Documents

FULL-TEXT PDF DOCUMENT
Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs
in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV Transmission in the United States.
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines

FULL TEXT PDF DOCUMENT
Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines

ARV Main Page Main New/Newsworthy
Home Page

Tipranavir Main Page